Management of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility

Eur J Neurol. 2006 Aug;13(8):e2. doi: 10.1111/j.1468-1331.2006.01555.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Integrin alpha4 / immunology*
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Natalizumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Integrin alpha4